Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-01-16
1977-12-20
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260574, A61K 31135, C07C 9116, C07C 9128
Patent
active
040642712
ABSTRACT:
5,6-Dialkoxy-2-tetralones (I) are disclosed as useful intermediates in the synthesis of 2-amino-5,6-dialkoxytetralins (III) and 2-amino-5,6-dihydroxytetralins (IV). Compounds of the groups III and IV are potent emetics.
REFERENCES:
patent: 2632024 (1953-03-01), Grob
patent: 3574762 (1971-04-01), Nagato et al.
J. D. McDermed et al., J. Med. Chem. 18, 362 (1975).
Cannon, et al., Journal of Med. Chem. 1972, vol. 15, No. 4, pp. 348-350.
W. K. Sprenger et al., Journal of Med. Chem. vol. 12, pp. 487-490 May 1969.
J. G. Cannon et al., J. Het. Chem. Aug. 1972, pp. 959-962.
McDermed John D.
McKenzie Gerald M.
Phillips Arthur P.
Brown Donald
Burroughs Wellcome Co.
Friedman Stanley J.
LandOfFree
Emetic tetralones and the use thereof for inducing regurgitation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Emetic tetralones and the use thereof for inducing regurgitation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Emetic tetralones and the use thereof for inducing regurgitation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-600391